Listen on the go
CORRECT!
Next question
touchNEUROLOGY touchNEUROLOGY

Start Learning

Touch Loading image
journal placeholder
JOURNALS
Start Learning
Prof. Konstantin Slavin leads the future of neuromodulation as new INS President
JOURNALS
Start Learning
Dr Amit Bar-Or receives prestigious 2025 John Dystel Prize for MS Research
JOURNALS
Start Learning
American Academy of Sleep Medicine releases new clinical practice guidelines for treating restless legs syndrome
CONFERENCE HUB
Start Learning
Movement disorders at EAN 2024: Key highlights and beyond
touchFEATURE
Start Learning
Friedreich ataxia – from genetic mutations to clinical symptoms
Sponsored content
JOURNALS
Start Learning
Challenges and motivations in neurocritical care: Insights from Dr Eric Lawson
touchROUNDTABLE
Start Learning
Integrating the ALS genetic counseling and testing guidelines: considerations for your practice
Sponsored content
Brain head human mental idea mind 3D illustration background
JOURNALS
Start Learning
Psychosis in Alzheimer’s Disease: A Review of Current and Prospective Therapeutic Strategies
touchMEETING HIGHLIGHTS
Start Learning
Navigating BTK Dynamics in Multiple Sclerosis
Sponsored content
JOURNALS
Start Learning
FDA approves ONAPGO™ for Parkinson’s Disease “Off” episodes

to view Favourites, Keep Notes and Track CME Credits

Favourites
New guidelines for epilepsy and pregnancy: AAN, AES and SMFM collaboration
View
Psychosis in Alzheimer’s Disease: A Review of Current and Prospective Therapeutic Strategies
View
Stigma and Alzheimer’s dementia: A Q&A with Dianne Gove, Alzheimer Europe
View
Pharmacological management of agitation in Alzheimer’s dementia: Rationale and evidence for new and emerging treatment options
View
The potential of BTKi therapies in delaying MS progression
View
American Academy of Sleep Medicine releases new clinical practice guidelines for treating restless legs syndrome
View
EAN 2024: Late-breakers in movement disorders, aging and dementia
View
Turning your clinical expertise into business success
View
Genetic counseling and testing: advancements, barriers, and opportunities in rare disease
View
Improving patient care in rare neuroimmunological disorders: clinical evidence and real-world experience with complement inhibition therapy
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup